AMED icon

Amedisys

97.16 USD
-0.07
0.07%
At close Jun 13, 4:00 PM EDT
After hours
97.16
+0.00
0.00%
1 day
-0.07%
5 days
3.62%
1 month
2.81%
3 months
4.94%
6 months
13.40%
Year to date
6.89%
1 year
5.98%
5 years
-44.76%
10 years
155.82%
 

About: Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

Employees: 19,000

0
Funds holding %
of 7,296 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

41% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 37

38% more repeat investments, than reductions

Existing positions increased: 110 | Existing positions reduced: 80

4% more funds holding

Funds holding: 285 [Q4 2024] → 296 (+11) [Q1 2025]

1% more capital invested

Capital invested by funds: $2.64B [Q4 2024] → $2.67B (+$22.8M) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 10 [Q4 2024] → 10 (+0) [Q1 2025]

1.2% less ownership

Funds ownership: 88.95% [Q4 2024] → 87.76% (-1.2%) [Q1 2025]

97% less call options, than puts

Call options by funds: $6.96M | Put options by funds: $205M

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$100
3%
upside
Avg. target
$100
3%
upside
High target
$100
3%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
RBC Capital
Ben Hendrix
3%upside
$100
Outperform
Reiterated
16 Apr 2025

Financial journalist opinion

Based on 3 articles about AMED published over the past 30 days

Positive
Zacks Investment Research
1 day ago
Here's Why You Should Retain AMED Stock in Your Portfolio for Now
Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.
Here's Why You Should Retain AMED Stock in Your Portfolio for Now
Neutral
Zacks Investment Research
3 weeks ago
AMED or CHE: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Amedisys (AMED) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
AMED or CHE: Which Is the Better Value Stock Right Now?
Negative
Zacks Investment Research
3 weeks ago
Are Medical Stocks Lagging Amedisys (AMED) This Year?
Here is how Amedisys (AMED) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Amedisys (AMED) This Year?
Positive
Zacks Investment Research
1 month ago
AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise
Amedisys delivers first-quarter top-line growth across three of its segments, namely Home Health, Hospice and High Acuity Care.
AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise
Positive
Zacks Investment Research
1 month ago
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
Positive
Zacks Investment Research
1 month ago
Amedisys (AMED) Tops Q1 Earnings Estimates
Amedisys (AMED) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $1.03 per share a year ago.
Amedisys (AMED) Tops Q1 Earnings Estimates
Neutral
GlobeNewsWire
1 month ago
Amedisys Reports First Quarter 2025 Financial Results
BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025.
Amedisys Reports First Quarter 2025 Financial Results
Neutral
Zacks Investment Research
1 month ago
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?
Positive
Zacks Investment Research
2 months ago
Why Is Amedisys (AMED) Up 1.3% Since Last Earnings Report?
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?
Why Is Amedisys (AMED) Up 1.3% Since Last Earnings Report?
Positive
Zacks Investment Research
2 months ago
Here's Why You Should Retain AMED Stock in Your Portfolio Now
Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.
Here's Why You Should Retain AMED Stock in Your Portfolio Now
Charts implemented using Lightweight Charts™